| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/20/2011 | US20110014264 Medical Devices Having Nanostructured Regions For Controlled Tissue Biocompatibility And Drug Delivery |
| 01/20/2011 | US20110014263 Silk Fibroin Hydrogels and Uses Thereof |
| 01/20/2011 | US20110014260 System and method for liver cell culture and maturation |
| 01/20/2011 | US20110014258 Gradient coating for biomedical applications |
| 01/20/2011 | US20110014123 RNA interference mediating small RNA molecules |
| 01/20/2011 | US20110014121 Modulators of cxcr7 |
| 01/20/2011 | CA2768505A1 Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor and erythropoietin production inducer |
| 01/20/2011 | CA2768342A1 Humic substances and therapeutic uses thereof |
| 01/20/2011 | CA2767764A1 Heterocyclic compound and use thereof |
| 01/19/2011 | EP2275557A1 Albumin fusion proteins |
| 01/19/2011 | EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 01/19/2011 | EP2275450A1 Treatment with anti-ERBB2 antibodies |
| 01/19/2011 | EP2275416A1 Biologically active methylene blue derivatives |
| 01/19/2011 | EP2275414A1 Cyclopentylacrylic acid amide derivative |
| 01/19/2011 | EP2275411A2 Reformatsky Reagent in Stable Form and Process for Producing the Same |
| 01/19/2011 | EP2275410A1 Process for production of compound having antagonistic activity on npyy5 receptor, and useful crystal |
| 01/19/2011 | EP2275404A1 Homocysteine synthase inhibitor |
| 01/19/2011 | EP2275135A1 Therapeutic for hepatic cancer |
| 01/19/2011 | EP2275117A1 GLP-1, exendin-4, peptide analogs and uses thereof |
| 01/19/2011 | EP2275114A1 Pharmaceutical composition for treating or preventing cancer which induces dendritic cell-like differentiation of monocytes to increase anticancer immune activity |
| 01/19/2011 | EP2275109A2 Pregnane steroids for use in the treatment of CNS disorders |
| 01/19/2011 | EP2275108A1 Pharmaceutical preparation comprising dpp-iv inhibitor and other diabetes therapeutic agent in concomitant or combined form |
| 01/19/2011 | EP2275102A1 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 01/19/2011 | EP2275091A1 Pharmaceutical compositions comprising adsorbates of an amorphous drug |
| 01/19/2011 | EP1547614B1 Medicinal composition for inhibiting the expression of atp-citrate lyase and use thereof |
| 01/19/2011 | EP1481969B1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2011 | EP1433776B1 Carba-sugar amine derivatives and treatments for disorder of glycolipid metabolism containing the same as the active ingredient |
| 01/19/2011 | EP1432416B1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 01/19/2011 | EP1365808B1 Compositions for antitumour treatment containing ecteinascidin 743 |
| 01/19/2011 | EP1337234B1 Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling |
| 01/19/2011 | EP1330442B1 Phthalazinone derivatives |
| 01/19/2011 | EP1325019B1 Antisense modulation of clusterin expression |
| 01/19/2011 | EP1252300B1 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 01/19/2011 | EP1185296B1 Prevention and treatment of amyloidogenic diseases |
| 01/19/2011 | CN1989855B Cordyceps sinensis cigarette and process for manufacturing same |
| 01/19/2011 | CN1950389B Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 01/19/2011 | CN1935181B Animal medicament with the functioin of curing infectious bronchitis of chicken, and its preparing method |
| 01/19/2011 | CN101952281A Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect |
| 01/19/2011 | CN101952280A Bicyclic heterocyclic derivative |
| 01/19/2011 | CN101952279A Azolylmethyloxiranes, use thereof and agents containing the same |
| 01/19/2011 | CN101951953A Pharmaceutical composition comprising anti-GRP78 antibody as active ingredient |
| 01/19/2011 | CN101951935A Therapeutic agent for cerebral ischemic injury |
| 01/19/2011 | CN101948859A shRNA expression vector expressed by specificity inhibitor SET protein, construction method and application thereof |
| 01/19/2011 | CN101948858A RNA (Ribose Nucleic Acid) interference recombination vector of SET (Patient SE Translocation) genes and establishment method and application thereof |
| 01/19/2011 | CN101948527A Mature peptide of fish somatostatin and application thereof |
| 01/19/2011 | CN101948439A Extraction method and application to medicine of active alkaloid compounds in cervus nippon temminck |
| 01/19/2011 | CN101947315A Application of Chinese medicinal bitter apricot seeds in lysozyme sodium alginate microspheres |
| 01/19/2011 | CN101947306A Treatment of T-cell mediated diseases |
| 01/19/2011 | CN101947290A Medicament with yin-nourishing effect |
| 01/19/2011 | CN101560213B Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application |
| 01/19/2011 | CN101429151B IDO restrainer containing (E)-4-(beta-bromo vinyl)benzoyloxy structure and preparation method thereof |
| 01/19/2011 | CN101362731B Heterocyclic compounds and methods of use |
| 01/19/2011 | CN101237885B Agent for regeneration and/or protection of nerves |
| 01/19/2011 | CN101160290B 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 01/19/2011 | CN101120921B Target preparation consisting of liposome and nucleic acid coating contrast agent |
| 01/19/2011 | CN101062080B Medicinal composition for relieving fatigue and preparing process thereof |
| 01/19/2011 | CN101014578B Triazole derivative or salt thereof |
| 01/18/2011 | US7872142 Coumarin derivatives useful as TNFα inhibitors |
| 01/18/2011 | US7872133 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 01/18/2011 | US7872129 Nitrogen compounds such as (6-(3-Methylaminopropyl)-2-(2-tri-fluoromethylphenyl)pyrimidin-4-yl)-(1H -pyrazolo(3,4-b)pyridin-3-yl)-amine, use as glycogen synthase kinase-3 (GSK-3) antagonists |
| 01/18/2011 | US7872125 1-Methyl,3-((1,3-dichloro-phenyl)-carbonylamino-(1-carboxy- eth-1,2-ylene)-(1,4-phenylene)-)quinazolin-2,4-dione; inhibiting the adhesion of VCAM-1 (vascular cellular adhesion molecules-1) to alpha-4 integrin; antiinflammatory agents; cardiovascular disorders; multiple sclerosis; antiarthritic agent |
| 01/18/2011 | US7872094 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) |
| 01/18/2011 | US7872035 Angiotensin II antagonists |
| 01/18/2011 | US7872030 Use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts |
| 01/18/2011 | US7871996 Contacting nitric oxide synthase with a corrin derivative; binding nitric oxide synthase but not nitric oxide; inflammatory, neurological disease, conjunctivitis, cystitis, inflammatory bowel disease, nephritis, glomerulonephritis, hepatitis, arteritis, vasculitis, cerebritis, vaginitis |
| 01/18/2011 | US7871994 at least one ingestion period preceding the permanent administration of hormone daily units has an ingestion pause in which either no daily units or units with a much lower hormone content is given |
| 01/18/2011 | US7871984 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
| 01/18/2011 | US7871798 Mammalian cells that express VEGF-D polypeptides |
| 01/18/2011 | US7871644 Mixture of drug, aminoacrylate polymer and acid |
| 01/18/2011 | US7871643 Pharmaceutical form having a two-layer separating layer |
| 01/18/2011 | US7871620 Immunoliposomes that optimize internationalization into target cells |
| 01/18/2011 | US7871606 Use of stimulated peripheral-blood mononuclear cells for the treatment of cancerous diseases |
| 01/18/2011 | CA2568590C Propane-1,3-dione derivative or salt thereof useful as gnrh receptor antagonist |
| 01/18/2011 | CA2500225C Pyrazole compounds |
| 01/18/2011 | CA2493310C 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition |
| 01/18/2011 | CA2481876C Inhalation kit comprising inhalable powder of tiotropium |
| 01/18/2011 | CA2477769C Ophthalmic composition comprising ascomycin |
| 01/18/2011 | CA2466642C Injectable depot composition |
| 01/18/2011 | CA2462374C Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage |
| 01/18/2011 | CA2441964C New pharmaceutical compositions based on anticholinergics and endothelin antagonists |
| 01/18/2011 | CA2440472C Methods of treating acne |
| 01/18/2011 | CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 01/18/2011 | CA2432077C Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
| 01/18/2011 | CA2416874C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/18/2011 | CA2402893C .alpha.-amylase activity inhibitor |
| 01/18/2011 | CA2385444C Humanin, a polypeptide suppressing neuronal death |
| 01/18/2011 | CA2383737C Muc-1 derived peptides |
| 01/18/2011 | CA2372850C Synergistic combination comprising roflumilast and a pde-3 inhibitor |
| 01/18/2011 | CA2321881C Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 01/18/2011 | CA2310534C Methods and compositions for treating primary and secondary tumors of the central nervous system (cns) |
| 01/18/2011 | CA2284399C Use of magnesium (mg2+) for the preparation of a therapeutic composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy |
| 01/18/2011 | CA2269895C Use of ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition containing such extract |
| 01/13/2011 | WO2011005473A2 Methods for treating or preventing fatigue |
| 01/13/2011 | WO2011005290A1 Disubstituted oxadiazole derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 01/13/2011 | WO2011004882A1 Acid pump antagonist for treatment of diseases associated with abnormal gastrointestinal movement |
| 01/13/2011 | WO2011004843A1 Pharmaceutical composition for treatment of sirs or highly pathogenic influenza infection |
| 01/13/2011 | WO2011004734A1 Carboxymethylarginine production inhibitor and collagen denaturation inhibitor |
| 01/13/2011 | WO2011004733A1 Activity enhancer for oxidized protein hydrolase |
| 01/13/2011 | WO2011004610A1 Azabicyclo compound and salt thereof |
| 01/13/2011 | WO2011004604A1 Diphenyl sulfide derivatives and medicines containing same as active ingredient |